Enhancing Immunological Control of SARS-CoV-2

Project Code

MRCIIAR24Ca Stanton

Research Theme

Infection, Immunity, Antimicrobial Resistance and Repair

Full Project Description

Please download the below document for a full project description and to see the full supervisory team.


Neutralizing antibodies are key to preventing transmission of SARS-CoV-2, however the virus can rapidly mutate to avoid these. Furthermore, once infected, neutralizing antibodies cannot access intracellular virus. Therefore, antibodies that recognise cell-associated virus are critical. However, current vaccines fail to induce these. We will investigate how this activity can be induced, as the basis for next-generation and variant-resistant coronavirus vaccines.

Lead Supervisor

Professor Richard Stanton

Lead Supervisor Email


University Affiliation